Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
6.5%
% of FHLC's 368 holdings also in PJP
100.0%
% of PJP's 22 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.6% | 6.0% | 6.0% |
|
JOHNSON & JOHNSON | 5.7% | 6.0% | 5.7% |
|
MERCK & CO. INC. | 5.3% | 5.6% | 5.3% |
|
ABBVIE INC | 4.9% | 6.2% | 4.9% |
|
ABBOTT LABORATORIES | 2.9% | 5.6% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 7.5% |
|
ELI LILLY & CO | 5.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
ELEVANCE HEALTH INC | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
STRYKER CORP | 1.9% |
|
BOSTON SCIENTIFIC CORP | 1.8% |
 |
MEDTRONIC PLC | 1.8% |
FHLC Underweight Relative to PJP
|
GERON CORP | -4.8% |
|
REGENERON PHARMACEUTICALS | -4.3% |
|
UNITED THERAPEUTICS CORP | -4.1% |
|
LIGAND PHARMACEUTICALS-CL B | -4.0% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.9% |
|
SUPERNUS PHARMACEUTICALS INC | -3.9% |
|
INNOVIVA, INC. | -3.8% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
AMGEN INC | -3.6% |
|
PERRIGO CO | -3.5% |